Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TVTX
Recent news which mentions TVTX
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Tickers
NVFY
OCUL
ONDS
OPK
Tags
PMVP
QSI
SMFR
From
Benzinga
4 Analysts Have This to Say About Travere Therapeutics
December 05, 2022
Tickers
TVTX
Tags
Market News
Analyst Ratings
TVTX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Tickers
AKTX
ALGT
ALK
AOMR
Tags
Analyst Ratings
H
ALGT
From
Benzinga
Where Travere Therapeutics Stands With Analysts
December 05, 2022
Tickers
TVTX
Tags
Market News
TVTX
Analyst Ratings
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 22, 2022
Tickers
SONN
SOUN
STOK
STRC
Tags
TIL
BZI/ftw
USM
From
Benzinga
Travere Therapeutics Earnings Perspective: Return On Capital Employed
November 03, 2022
Tickers
TVTX
Tags
Benzinga
TVTX
Earnings
From
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
Small Cap
Biotech
Health Care
From
Benzinga
Recap: Travere Therapeutics Q3 Earnings
October 27, 2022
Tickers
TVTX
Tags
BZI/Recaps
Market News
Earnings
From
Benzinga
Earnings Scheduled For October 27, 2022
October 27, 2022
Tickers
OIS
ONTO
OPCH
OPI
Tags
WRLD
SUZ
ZEN
From
Benzinga
Earnings Outlook For Travere Therapeutics
October 26, 2022
Tickers
TVTX
Tags
Benzinga
Market News
TVTX
From
Benzinga
Analyst Cuts Price On Travere Therapeutics Citing Expected Delayed PDUFA
October 14, 2022
Tickers
TVTX
Tags
General
Price Target
Movers
From
Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
Tickers
ACHV
ACST
AMBP
ANGI
Tags
ONVO
CZOO
WISH
From
Benzinga
Expert Ratings for Travere Therapeutics
October 14, 2022
Tickers
TVTX
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
FDA Requests For Additional Monitoring For Travere Therapeutics' Sparsentan In Rare Kidney Disease
October 14, 2022
Tickers
TVTX
Tags
Trading Ideas
Benzinga
FDA
From
Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Tickers
BTTX
FSTR
HPK
LAZY
Tags
MFA
LNKB
USEG
From
InvestorPlace
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Tickers
BLTE
BNTX
CUE
GERN
Tags
PFE
Benzinga
FDA
From
Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
August 22, 2022
Tickers
CSLLY
TVTX
Tags
TVTX
Market News
Benzinga
From
Benzinga
Travere Therapeutics Return On Capital Employed Overview
August 15, 2022
Tickers
TVTX
Tags
Earnings
TVTX
BZI/ROCE
From
Benzinga
H.C. Wainwright reduces Travere Therapeutics (TVTX) PT’s price to $42
August 09, 2022
Tickers
TVTX
Tags
Analyst Rating
News
TVTX
From
Best Stocks
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
PDSB
AMGN
VIR
From
Benzinga
Recap: Travere Therapeutics Q2 Earnings
August 04, 2022
Tickers
TVTX
Tags
Earnings
News
Benzinga
From
Benzinga
FDA Says Travere's Sparsentan Data Not Sufficient For Accelerated Approval In One Indication
August 04, 2022
Tickers
TVTX
Tags
Market News
TVTX
Benzinga
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 03, 2022
Tickers
BCLI
CASI
CCRN
ENVB
Tags
MOTS
CASI
CCRN
From
Benzinga
4 Analysts Have This to Say About Travere Therapeutics
July 26, 2022
Tickers
TVTX
Tags
Market News
TVTX
Analyst Ratings
From
Benzinga
Where Travere Therapeutics Stands With Analysts
July 26, 2022
Tickers
TVTX
Tags
Market News
TVTX
Analyst Ratings
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 17, 2022
Tickers
ABIO
ADAG
CASI
CYCC
Tags
ITRM
RUBY
ADAG
From
Benzinga
Analyst Ratings for Travere Therapeutics
May 17, 2022
Tickers
TVTX
Tags
Market News
TVTX
Analyst Ratings
From
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Travere Therapeutics: Here's What You Need To Know
May 17, 2022
Tickers
TVTX
Tags
Benzinga
BZI/AAR/UPDATE
TVTX
From
Benzinga
FDA Accepts Travere Therapeutics' NDA for Sparsentan with Priority Review
May 16, 2022
Tickers
TVTX
Tags
Biotech
Small Cap
News
From
Benzinga
Here's Why Travere Therapeutics Shares Are Rising Today
May 16, 2022
Tickers
TVTX
Tags
Benzinga
Trading Ideas
TVTX
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.